Increasing age population who needs better healthcare, increase in chronic disease and need for better diagnosis and treatment are few driving factors that are impacting the flow cytometry market state AMR analysts Debbie Shields and Rohini Patil.
The primary companies involved in the global Flow cytometry market are Advanced Analytical Technologies Inc., Merck Millipore, Becton, Dickinson & co, Beckman Coulter, eBioscience, Partech, Life technologies corp., Luminex Corp., Amnis Corp., Morphosys AG
The report segments the global flow cytometry market into component, technology, application, end user, and geography. Based on component, the market is classified into instruments, reagents, software, and services. Instruments garnered the highest revenue in 2014 due to technological advancements, demand for highly efficient replaceable components, and widening the scope of flow cytometry applications in newer diseases. It is expected to maintain the foothold on the market in 2020 as well, as an increase in modularity, accessibility, incorporation of imaging capabilities, availability of wavelengths and targets and size reduction would drive the adoption of instruments by end users in the future. Meanwhile, the reagents sub-segment is poised to have the highest growth rate of 12% CAGR during the forecast period, as different types of reagents that find diverse usability becomes available.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/90
The report valued the market at $3 billion in 2012 and projected it to reach $6.5 billion by 2020, registering a mammoth CAGR of 30.9% during the forecast period of 2014-2022.
The market is driven by a rise in demand for global flow cytometry, as a result of an increasing aging population, an increase in chronic disease, and the need for better diagnosis and treatment. Enhanced precision in the results and the availability of numerous flow cytometry techniques such as multicolor and multi-parameter flow cytometry has also assisted its adoption, especially in a majority of developed countries. However, market growth is impeded by high instrument costs and size, lack of awareness among probable users and the need for trained personnel.
Only two kinds of technologies are implemented in flow cytometry – bead-based and cell-based. Although cell-based technique dominates the present market in terms of revenue and adoption, bead-based technique is expected to be the most widely used technology by 2020. In 2011, North America occupied 43.5% of the global flow cytometry market share at $1.2 billion. The region is expected to grow at a CAGR of 10.1% and attain a market size of $2.8 billion by 2020.
